Tissue Repair Ltd has released a press release.
Phase 3 Clinical Trial Programme for TR987
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Tissue Repair
- Takeover Panel Media release & Independent Director changes
- Appendix 4E and Annual Report 30 June 2024
- Tony Charara Co-founder appointed as CEO
- TGA approval granted for Tissue Repair TR Pro
- Appendix 4D and Half Year Report to 31 December 2023
Later from Tissue Repair
- Appendix 4D and Half Year Report to 31 December 2024
- Major Distribution Agreement secured for TR Pro
- Appendix 4E and Annual Report 30 June 2025
- Pause in Trading
- Response to ASX Price Query
Follow Tissue Repair into a list and get an email when it puts out news.
Follow Tissue Repair